B.J. Riis

2.5k citations

40 papers · 1.9k indexed · 1 hit paper · h-index 17

Immunology and Allergy top 0.2%
Physiology top 2%
Dermatology top 0.5%
Pulmonary and Respiratory Medicine top 10%
Molecular Biology

Co-authors: Stephen R. Durham W. Emminger Alexander Kapp Ronald Dahl S. Rak Jan G.R. de Monchy Claus Christiansen Jens Andersen
Topics: Allergic Rhinitis and Sensitization (15 papers)Asthma and respiratory diseases (10 papers)Dermatology and Skin Diseases (7 papers)
Cited by: Immunology and Allergy Dermatology Physiology
Journals: JAMA Journal of Allergy and Clinical Immunology European Respiratory Journal
Partner nations: Denmark United States Germany

In The Last Decade

B.J. Riis

39 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

2012 376 citations Stephen R. Durham, W. Emminger et al. Journal of Allergy and Clinical Immunology profile →

Peers

Countries citing papers authored by B.J. Riis

Since Specialization

Citations

This map shows the geographic impact of B.J. Riis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.J. Riis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.J. Riis more than expected).

Fields of papers citing papers by B.J. Riis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.J. Riis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.J. Riis. The network helps show where B.J. Riis may publish in the future.

Co-authorship network of co-authors of B.J. Riis

This figure shows the co-authorship network connecting the top 25 collaborators of B.J. Riis. A scholar is included among the top collaborators of B.J. Riis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.J. Riis. B.J. Riis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biomarkers of bone and cartilage turnover CTX-I and CTX-II predict total joint replacements in osteoarthritis 2019 ·Osteoarthritis and Cartilage ·(unknown),Anne‐Christine Bay‐Jensen,M.A. Karsdal,I. Byrjalsen,J.R. Andersen,B.J. Riis,Claus Christiansen,Asger Reinstrup Bihlet	6
2	Comparison of the novel CompEx asthma exacerbation endpoint to the ATS/ERS adapted moderate/severe asthma exacerbation definition used in the MITRA trial 2019 ·Respiratory Medicine ·Göran Eriksson,Hendrik Nolte,Christian Ljørring,B.J. Riis,J. Christian Virchow	0
3	Segregating OA patients with and without joint inflammation using two biomarkers of connective tissue inflammation 2015 ·Osteoarthritis and Cartilage ·Anne‐Christine Bay‐Jensen,I. Byrjalsen,Asger Reinstrup Bihlet,(unknown),B.J. Riis,Claus Christiansen,M.A. Karsdal	1
4	Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials 2015 ·Osteoarthritis and Cartilage ·M.A. Karsdal,I. Byrjalsen,Peter Alexandersen,Asger Reinstrup Bihlet,J.R. Andersen,B.J. Riis,Anne‐Christine Bay‐Jensen,Claus Christiansen	101
5	HDM sublingual AIT tablet is well-tolerated and effective in partly and uncontrolled allergic asthma 2014 ·European Respiratory Journal ·Vibeke Backer,(unknown),Hanne H. Villesen,(unknown),B.J. Riis,F. de Blay	3
6	SQ HDM SLIT-tablet (ALK) in treatment of asthma – Post hoc results from a randomised trial 2014 ·Respiratory Medicine ·F. de Blay,Piotr Kuna,Luis Prieto,(unknown),Dorthe Seitzberg,B.J. Riis,Giorgio Walter Canonica	54
7	Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1–31)NH2] in postmenopausal women with osteoporosis 2012 ·Bone ·Kim Henriksen,J.R. Andersen,B.J. Riis,Natasha Mehta,(unknown),Peter Alexandersen,I. Byrjalsen,Ivo Valter,Bettina S. Nedergaard,Christence Stubbe Teglbjærg,William Stern,(unknown),(unknown),Antonio Nino,Lorraine A. Fitzpatrick,C. Christiansen,M.A. Karsdal	46
8	SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trialbreakdown → 2012 ·Journal of Allergy and Clinical Immunology ·Stephen R. Durham,W. Emminger,Alexander Kapp,Jan G.R. de Monchy,S. Rak,Glenis Scadding,Peter Adler Würtzen,Jens Andersen,(unknown),B.J. Riis,Ronald Dahl	376
9	Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet 2010 ·Journal of Allergy and Clinical Immunology ·Stephen R. Durham,W. Emminger,Alexander Kapp,Giselda Colombo,Jan G.R. de Monchy,S. Rak,Glenis Scadding,Jens Andersen,B.J. Riis,Ronald Dahl	262
10	Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP) — Assessment of corresponding epitopes 2010 ·Clinical Biochemistry ·D.J. Leeming,Dorthe Vang Larsen,(unknown),(unknown),Sanne Skovgård Veidal,Rasmus Hjorth Nielsen,Kim Henriksen,(unknown),Vibeke Barkholt,B.J. Riis,I. Byrjalsen,Per Qvist,M.A. Karsdal	54
11	Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials 2010 ·The Journal of Clinical Pharmacology ·M.A. Karsdal,Kim Henriksen,Anne‐Christine Bay‐Jensen,(unknown),M. Arnold,Markus R. John,I. Byrjalsen,M. Azria,B.J. Riis,Per Qvist,Claus Christiansen	77
12	Sustained, disease-modifying effect of grass allergen tablet immunotherapy 1 year after completion of treatment 2009 ·Data Archiving and Networked Services (DANS) ·Stephen R. Durham,Ronald Dahl,Alexander Kapp,Giselda Colombo,J. de Monchy,S. Rak,B.J. Riis,W. Emminger	3
13	Influence of food intake on the bioavailability and efficacy of oral calcitonin 2009 ·British Journal of Clinical Pharmacology ·M.A. Karsdal,I. Byrjalsen,M. Azria,M. Arnold,(unknown),B.J. Riis,Claus Christiansen	33
14	Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon Calcitonin 2008 ·PubMed ·M.A. Karsdal,I. Byrjalsen,B.J. Riis,Claus Christiansen	50
15	Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years 2008 ·Journal of Allergy and Clinical Immunology ·Ronald Dahl,Alexander Kapp,Giselda Colombo,Jan G.R. de Monchy,S. Rak,W. Emminger,B.J. Riis,(unknown),Stephen R. Durham	160
16	Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage 2007 ·Allergy ·Stephen R. Durham,B.J. Riis	49
17	Development and validation of an electronic version of the Rhinoconjunctivitis Quality of Life Questionnaire 2007 ·Allergy ·Elizabeth F. Juniper,B.J. Riis,Bridget Juniper	33
18	Calcitonin is involved in cartilage homeostasis: Is calcitonin a treatment for OA? 2006 ·Osteoarthritis and Cartilage ·M.A. Karsdal,László B. Tankó,B.J. Riis,(unknown),Kim Henriksen,Roy D. Altman,Per Qvist,Claus Christiansen	48
19	Design for an ipriflavone multicenter European fracture study 1997 ·Calcified Tissue International ·Jean‐Yves Reginster,L. Bufalino,Claus Christiansen,J.-P. Devogelaer,C. Gennari,B.J. Riis,Christian Roux	5
20	Premenopausal bone loss: Fact or artifact? 1994 ·Osteoporosis International ·B.J. Riis	14

About B.J. Riis

B.J. Riis is a scholar working on Immunology and Allergy, Dermatology and Rheumatology, having authored 40 papers that have together received 1.9k indexed citations. Recurring topics across this work include Allergic Rhinitis and Sensitization (15 papers), Asthma and respiratory diseases (10 papers) and Dermatology and Skin Diseases (7 papers). The work is most often cited by research in Immunology and Allergy (1.2k citations), Dermatology (650 citations) and Physiology (1.2k citations). B.J. Riis has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Stephen R. Durham, W. Emminger, Alexander Kapp, Ronald Dahl, S. Rak, Jan G.R. de Monchy, Claus Christiansen, Jens Andersen, Glenis Scadding and M.A. Karsdal. Their work appears in journals such as JAMA, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact